Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.84B | 2.95B | 3.21B | 3.49B | 3.02B |
Gross Profit | 1.37B | 1.40B | 1.47B | 1.66B | 1.31B |
EBITDA | 320.07M | 400.35M | 455.01M | 592.69M | 328.90M |
Net Income | 185.51M | 232.50M | 250.04M | 339.75M | 109.72M |
Balance Sheet | |||||
Total Assets | 2.43B | 2.38B | 2.44B | 3.20B | 3.39B |
Cash, Cash Equivalents and Short-Term Investments | 412.93M | 351.21M | 211.75M | 984.29M | 1.10B |
Total Debt | 1.13B | 1.08B | 1.18B | 1.57B | 1.73B |
Total Liabilities | 1.58B | 1.53B | 1.64B | 2.25B | 2.45B |
Stockholders Equity | 854.56M | 845.25M | 796.41M | 950.19M | 938.03M |
Cash Flow | |||||
Free Cash Flow | 242.62M | 469.27M | 48.00M | 230.82M | 557.02M |
Operating Cash Flow | 298.79M | 529.13M | 88.36M | 268.26M | 589.89M |
Investing Cash Flow | -56.16M | -59.86M | -40.36M | -32.44M | -32.87M |
Financing Cash Flow | -174.82M | -332.64M | -819.27M | -352.71M | 324.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.51B | 12.91 | 44.55% | 7.95% | -1.08% | -8.20% | |
68 Neutral | $1.19B | 7.51 | 15.95% | 8.09% | -3.39% | -28.96% | |
68 Neutral | $1.95B | 11.07 | 12.19% | 4.26% | -0.95% | -10.51% | |
62 Neutral | C$5.29B | 8.93 | 20.23% | 3.14% | 3.09% | 8.49% | |
61 Neutral | $1.66B | 10.45 | 31.35% | ― | 1.45% | 59.09% | |
55 Neutral | $2.40B | 194.63 | -12.85% | ― | -2.62% | 0.93% | |
46 Neutral | $126.58M | ― | -521.67% | ― | -12.15% | 75.86% |
On July 8, 2025, Hali Borenstein, a member of Carter’s, Inc. Board of Directors, announced she will not seek re-election at the 2026 annual shareholders’ meeting. Her decision is not due to any disagreements with the company but to focus on her role as CEO of Reformation LLC and her family. Ms. Borenstein will continue her duties on the Board until the meeting in 2026, and the company expressed gratitude for her service.
The most recent analyst rating on (CRI) stock is a Sell with a $41.00 price target. To see the full list of analyst forecasts on Carter’s stock, see the CRI Stock Forecast page.
On May 14, 2025, Carter’s held its Annual Meeting of Stockholders, where all eleven director nominees were elected for a one-year term. Additionally, the stockholders approved the 2024 executive compensation and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2025. On May 20, 2025, Carter’s announced updates to its strategic plan and declared a $0.25 quarterly dividend, reflecting a realignment of its capital allocation strategy amid challenging market conditions and potential cost increases due to proposed tariffs. The company aims to return to consistent, profitable growth and will present its strategic plan in the upcoming earnings call.
The most recent analyst rating on (CRI) stock is a Hold with a $49.00 price target. To see the full list of analyst forecasts on Carter’s stock, see the CRI Stock Forecast page.